Published in Mass Spectrom Rev on March 17, 2005
Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics (2006) 2.14
Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics (2008) 2.08
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res (2009) 1.97
Precursor-ion mass re-estimation improves peptide identification on hybrid instruments. J Proteome Res (2008) 1.53
A straightforward and highly efficient precipitation/on-pellet digestion procedure coupled with a long gradient nano-LC separation and Orbitrap mass spectrometry for label-free expression profiling of the swine heart mitochondrial proteome. J Proteome Res (2009) 1.46
Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers. J Proteome Res (2009) 1.17
Analysis of intact protein isoforms by mass spectrometry. J Biol Chem (2011) 1.15
Proteomic technologies in the study of kinases: novel tools for the investigation of PKC in the heart. Pharmacol Res (2007) 0.94
Proteomic technologies for the discovery of type 1 diabetes biomarkers. J Diabetes Sci Technol (2010) 0.86
Proteomics and the analysis of proteomic data: an overview of current protein-profiling technologies. Curr Protoc Bioinformatics (2005) 0.84
Proteomics and mass spectrometry for cancer biomarker discovery. Biomark Insights (2007) 0.84
Analysis of protein isoforms: can we do it better? Proteomics (2012) 0.80
Differential Plasma Glycoproteome of p19 Skin Cancer Mouse Model Using the Corra Label-Free LC-MS Proteomics Platform. Clin Proteomics (2008) 0.79
Advances and challenges in biomarker development for type 1 diabetes prediction and prevention using omic technologies. Expert Opin Med Diagn (2010) 0.79
Immunoaffinity enrichment and liquid chromatography-selected reaction monitoring mass spectrometry for quantitation of carbonic anhydrase 12 in cultured renal carcinoma cells. Anal Chem (2010) 0.78
One-step acquisition of functional biomolecules from tissues. Proc Natl Acad Sci U S A (2010) 0.76
Combining high-throughput MALDI-TOF mass spectrometry and isoelectric focusing gel electrophoresis for virtual 2D gel-based proteomics. Methods (2016) 0.75
Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. J Proteome Res (2006) 4.32
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem (2004) 2.26
Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J Proteome Res (2004) 1.19
Harnessing immunity for cancer marker discovery. Nat Biotechnol (2003) 0.99
Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease. Mol Cell Proteomics (2008) 0.96
Autoantibody profiling for cancer detection. Clin Lab Med (2009) 0.92
Electrospray mass spectrometry for quantitative plasma proteome analysis. Methods Mol Biol (2009) 0.84
Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers. Genome Med (2014) 0.81
Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma. PLoS One (2011) 0.80
A systems approach to the proteomic identification of novel cancer biomarkers. Dis Markers (2010) 0.80
BiomarkerDigger: a versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers. Proteomics (2009) 0.80
Focus on breast cancer proteomics. Proteomics Clin Appl (2009) 0.75
It takes a village to develop biomarkers. J Proteome Res (2007) 0.75
The emerging field of protein microarrays. Proteomics (2003) 0.75